重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
3期
299-302
,共4页
倪鑫%赵洪伟%冯驰%季平%邱丽华%李勇%高翔%刘平%王涛
倪鑫%趙洪偉%馮馳%季平%邱麗華%李勇%高翔%劉平%王濤
예흠%조홍위%풍치%계평%구려화%리용%고상%류평%왕도
癌 ,鳞状细胞%口腔肿瘤%抗肿瘤联合他疗方案%不良反应
癌 ,鱗狀細胞%口腔腫瘤%抗腫瘤聯閤他療方案%不良反應
암 ,린상세포%구강종류%항종류연합타료방안%불량반응
carcinoma,squamous cell%mouth neoplasms%antineoplastic%adverse reaction
目的:对口腔鳞癌患者采用不同化疗给药途径并观察奈达铂(nedaplatin,NDP)和5‐氟尿嘧啶(5‐fluorouracil,5‐Fu)的疗效和不良反应。方法将64例口腔鳞癌患者分为术后普通静脉化疗组(IV组,32例)和术中即刻行颞浅动脉逆行置管化疗组(IA组,32例),两组化疗方案都为DNP和5‐Fu,其中IA组剂量为IV组的1/3,观察疗效和不良反应。结果IA组疗效优于IV组(P<0.05),同时IA组在骨髓抑制、胃肠道反应及口腔黏膜炎等化疗后并发症较IV组轻,差异有统计学意义(P<0.05)。结论术中IA疗效明显,不良反应轻且安全,适合临床推广。
目的:對口腔鱗癌患者採用不同化療給藥途徑併觀察奈達鉑(nedaplatin,NDP)和5‐氟尿嘧啶(5‐fluorouracil,5‐Fu)的療效和不良反應。方法將64例口腔鱗癌患者分為術後普通靜脈化療組(IV組,32例)和術中即刻行顳淺動脈逆行置管化療組(IA組,32例),兩組化療方案都為DNP和5‐Fu,其中IA組劑量為IV組的1/3,觀察療效和不良反應。結果IA組療效優于IV組(P<0.05),同時IA組在骨髓抑製、胃腸道反應及口腔黏膜炎等化療後併髮癥較IV組輕,差異有統計學意義(P<0.05)。結論術中IA療效明顯,不良反應輕且安全,適閤臨床推廣。
목적:대구강린암환자채용불동화료급약도경병관찰내체박(nedaplatin,NDP)화5‐불뇨밀정(5‐fluorouracil,5‐Fu)적료효화불량반응。방법장64례구강린암환자분위술후보통정맥화료조(IV조,32례)화술중즉각행섭천동맥역행치관화료조(IA조,32례),량조화료방안도위DNP화5‐Fu,기중IA조제량위IV조적1/3,관찰료효화불량반응。결과IA조료효우우IV조(P<0.05),동시IA조재골수억제、위장도반응급구강점막염등화료후병발증교IV조경,차이유통계학의의(P<0.05)。결론술중IA료효명현,불량반응경차안전,괄합림상추엄。
Objective Treat patients with oral squamous cell carcinomas with different chemotherapy administration route ,and observe the effects and adverse reaction of Nedaplatin (NDP) and 5‐Fluorouracil (5‐Fu) .Methods Sixty four patients with oral squamous cell carcinomas were randomly divided into two groups which included intravenous chemotherapy group (IV)(with 32 ca‐ses) and intra‐artery infusion via the superficial temporal artery group (IA)(with 32 cases) .Each group was treated with NDP and 5‐Fu .The dose of the IA group was one third of that of the IV group .Efficacy and side effect had been observed .Results Efficacy of the IA group was better than that of the IV group (P<0 .05) .Complications including bone marrow suppression ,gastrointestinal reactions and oral mucositis of the IA group was lighter than that of the IV group ,which was significantly different (P<0 .05) . Conclusion The retrograde intra‐arterial chemotherapy via the superficial temporal artery during the surgery is safe ,effective and useful ,and it is worth of further clinical application .